Elehear Beyond vs MDHearing Volt

The Elehear Beyond is a budget-priced OTC hearing aid that delivers A-grade performance in our lab testing, ranking #8 among 65 OTC hearing aids tested. At $431, this 2024 behind-the-ear device earned our Expert's Choice Award and represents strong value in the entry-level price tier. In our testing, the Beyond demonstrated particular strength in speech clarity in quiet environments, scoring 4.3/5—a strong result that sits 1.48 points above the OTC category average. Music streaming quality also impressed at 3.8/5, exceeding the category average by 1.88 points. Speech understanding in noisy settings scored 2.3/5, which is above the category average of 1.48/5 but remains mixed in absolute terms—a common challenge across OTC devices. Feedback handling proved excellent at 4.5/5, essentially matching the category average. Own-voice comfort scored 2.6/5, slightly above the OTC average but mixed overall—users sensitive to their own voice may notice some occlusion effects. The device uses a rechargeable battery and supports streaming to both iPhone and Android devices with hands-free functionality. The Elehear Beyond is well-suited for budget-conscious consumers seeking reliable speech clarity in quieter listening situations and quality audio streaming. Those who frequently encounter challenging noise environments may find the speech-in-noise performance adequate but not exceptional. Within its price range, the Beyond outperforms competitors including the Apple AirPods Pro 2 and Zepp Clarity Omni on overall sound quality.

The MDHearing Volt is a budget-priced prescription hearing aid available for $397, earning a B grade with a SoundScore of 3.1/5 in our lab testing. This behind-the-ear, rechargeable device ranks #32 of 36 prescription hearing aids tested, placing it in the top 86% of its category. In our standardized testing, the Volt demonstrates excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. This represents a genuine strength, as the device remained stable under our challenge protocols without audible squealing or whistling. However, speech performance presents significant limitations: speech in quiet scored 1.8/5 (1.57 points below the category average of 3.32), while speech in noise scored 1.0/5 (0.96 points below the 1.96 average). Own-voice comfort measured 2.6/5, a mixed result that falls 0.15 points below the category average. Music streaming is notably limited at 0.0/5, scoring 2.64 points below the category average—users prioritizing phone streaming should consider alternatives. The Volt showed no improvement between Initial and Tuned fits, with both configurations yielding identical scores of 3.1/5. The MDHearing Volt may suit budget-conscious consumers who prioritize basic amplification and excellent feedback stability over speech clarity or streaming features. However, shoppers in this price range should note that alternatives like the RxEars Rxi offer substantially higher performance at similar pricing.